Virtual Library

Start Your Search

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

Filter Results:

Show Only Available Presentations

  • +

    FP09 - Novel Therapeutics and Targeted Therapies

    • Type: Posters (Featured)
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 4
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
  • +

    IS01 - Industry Symposium Sponsored by Mirati Therapeutics: Rapid Progress During a Pandemic: Emerging Therapeutic Options for NSCLC

    • Type: Industry Supported Symposium
    • Track: N.A.
    • Presentations: 5
    • Coordinates: 9/08/2021, 12:00 - 13:00, Industry Symposium Auditorium via Industry Hub
    • +

      IS01.01 - Welcome and Introduction

      12:00 - 12:05  |  Presenter: Pasi A. Janne

      • Abstract

      No abstract available for this presentation

    • +

      IS01.04 - Advances In NSCLC: Targeted Therapies, Including Targeting KRAS-Driven NSCLC

      12:35 - 12:50  |  Presenter: Pasi A. Janne

      • Abstract

      No abstract available for this presentation

  • +

    OA15 - Upcoming Molecular Targeted Agents for EGFR exon 20 Insertion and MET Skipping Mutation

    • Type: Oral
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 6
    • Moderators:Helena A Yu
    • Coordinates: 9/12/2021, 18:45 - 19:45, Program Auditorium
    • +

      OA15.01 - Mobocertinib in EGFR Exon 20 Insertion–Positive Metastatic NSCLC Patients With Disease Control on Prior EGFR TKI Therapy

      18:45 - 18:55  |  Presenter: Alexander Spira

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA15.02 - Phase 1 Studies of DZD9008, an Oral Selective EGFR/HER2 Inhibitor in Advanced NSCLC with EGFR Exon20 Insertion Mutations

      18:55 - 19:05  |  Presenter: Pasi A. Janne

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA15.03 - Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS

      19:05 - 19:15  |  Presenter: Alexander Spira

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.